PDCD1 and neoplasm: The final step in the tumor-immune cycle is the recognition and killing of tumor cells by effector T cells, and the most common strategies used by tumor cells to evade immune attack are the expression of the negative regulatory molecule programmed cell death 1(PD-1)/L1 and the generation of mutant tumor antigens through immunoediting (Blank et al., 2004).